Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Publications
▹
Home
Publication
Intrarenal dopamine modulates progressive angiotensin II-mediated renal injury.
Authors
Yang S, Yao B, Zhou Y, Yin H, Zhang MZ, Harris RC
Submitted By
Raymond Harris on 8/1/2012
Status
Published
Journal
American journal of physiology. Renal physiology
Year
2012
Date Published
3/1/2012
Volume : Pages
302 : F742 - F749
PubMed Reference
22169008
Abstract
It is well-recognized that excessive angiotensin II (ANG II) can mediate
progressive renal injury. Previous studies by us and others have indicated that
dopamine may modulate actions of ANG II in the kidney. The current studies
investigated whether altering intrarenal dopamine levels affected ANG
II-mediated renal fibrosis. We utilized a model of increased intrarenal
dopamine, catechol-O-methyl-transferase knockout (COMT KO) mice, which have
increased kidney dopamine levels due to deletion of a major intrarenal
dopamine-metabolizing enzyme. In wild-type mice, chronic ANG II infusion
increased renal expression of both of the major dopamine-metabolizing enzymes,
COMT and monoamine oxidase. After 8 wk of ANG II infusion, there were no
significant differences in blood pressure between wild-type and COMT KO mice.
Compared with wild-type, COMT KO mice had decreased albuminuria and
tubulointerstitial injury. In response to ANG II infusion, there was decreased
expression of both glomerular and tubulointerstitial injury markers
(fibronectin, connective tissue growth factor, fibroblast-specific protein-1,
collagen I, podocyte vascular endothelial growth factor) in COMT KO mice. We
recently reported that ANG II-mediated tubulointerstitial fibrosis is mediated
by src-dependent epidermal growth factor receptor (EGFR) activation. In aromatic
l-amino acid decarboxylase knockout (AADC KO) mice, a model of intrarenal
dopamine deficiency due to selective proximal tubule AADC deletion, which
inhibits intrarenal dopamine synthesis, ANG II infusion further increased
expression of p-src and pTyr845-EGFR. In contrast, their expression was markedly
attenuated in COMT KO mice. These results demonstrate a role for intrarenal
dopamine to buffer the detrimental effects of ANG II upon the kidney.
Investigators with authorship
Name
Institution
Raymond Harris
Vanderbilt University
Complications
All Complications
Bioinformatics
Bone
Cardiomyopathy
Cardiovascular
Gastro-Intestinal (GI)
Nephropathy
Neuropathy & Neurocognition
Pediatric Endocrinology
Retinopathy
Uropathy
Wound Healing
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!